FDA Clears NRX-101: Investigational Drug for Complicated UTIs by NRx

FDA Clears NRX-101: Investigational Drug for Complicated UTIs by NRx

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage biopharmaceutical company, has announced a significant milestone with the FDA’s clearance of its…

Read More »